On June 10, 2025, Zomedica Corp. held its annual meeting where shareholders elected eight directors and ratified Grant Thornton LLP as auditors for 2025, but did not approve the executive compensation proposal. The election results showed significant support for the board but raised concerns over executive pay with 82,373,446 votes against it.